loadpatents
name:-0.0070171356201172
name:-0.052737951278687
name:-0.00060105323791504
Merck Frosst Canada & Co. Patent Filings

Merck Frosst Canada & Co.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merck Frosst Canada & Co..The latest application filed is for "substituted pyridines as selective cyclooxygenase-2 inhibitors".

Company Profile
0.50.6
  • Merck Frosst Canada & Co. - Quebec CA
  • Merck Frosst Canada & Co. - Kirkland Province of Quebec CA
  • Merck Frosst Canada & Co. -
  • Merck Frosst Canada & Co. - Rairkland CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Granule formation
Grant 8,007,830 - Down August 30, 2
2011-08-30
Cathepsin cysteine protease inhibitors
Grant 7,687,524 - Boyd , et al. March 30, 2
2010-03-30
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,501 - Dufresne , et al. November 24, 2
2009-11-24
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,502 - Berthelette , et al. November 24, 2
2009-11-24
Polymorphic form of montelukast sodium
Grant 7,560,559 - Chou , et al. July 14, 2
2009-07-14
Cathepsin cysteine protease inhibitors
Grant 7,407,959 - Gauthier , et al. August 5, 2
2008-08-05
Cathepsin cysteine protease inhibitors
Grant 7,405,229 - Bayly , et al. July 29, 2
2008-07-29
Cathepsin cysteine protease inhibitors
Grant 7,375,134 - Bayly , et al. May 20, 2
2008-05-20
Cyanoalkylamino derivatives as protease inhibitors
Grant 7,371,747 - Black , et al. May 13, 2
2008-05-13
Sulphonamido-substituted bridged bicycloalkyl derivatives
Grant 7,365,196 - Belanger , et al. April 29, 2
2008-04-29
Quinolinones as prostaglandin receptor ligands
Grant 7,348,433 - Dube , et al. March 25, 2
2008-03-25
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
Grant 7,317,036 - Berthelette , et al. January 8, 2
2008-01-08
Cathepsin cysteine protease inhibitors
Grant 7,279,478 - Boyd , et al. October 9, 2
2007-10-09
Aryldifluoromethylphosphonic acids for treatment of diabetes
Grant 7,163,932 - Dufresne , et al. January 16, 2
2007-01-16
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
Grant 7,144,913 - Wang , et al. December 5, 2
2006-12-05
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
Grant 7,019,022 - Beaulieu , et al. March 28, 2
2006-03-28
Substituted 8-arylquinolune PDE4 inhibitors
Grant 6,919,353 - Dube , et al. July 19, 2
2005-07-19
Tri-aryl-substituted-ethane PDE4 inhibitors
Grant 6,841,564 - Freisen , et al. January 11, 2
2005-01-11
Cathepsin cysteine protease inhibitors
Grant 6,835,727 - Okamoto , et al. December 28, 2
2004-12-28
Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
Grant 6,777,433 - Leblanc , et al. August 17, 2
2004-08-17
Alkyne-aryl phosphodiesterase-4 inhibitors
Grant 6,743,802 - Guay , et al. June 1, 2
2004-06-01
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
Grant 6,740,666 - Macdonald , et al. May 25, 2
2004-05-25
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20040029921 - Dube, Daniel ;   et al.
2004-02-12
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
Grant 6,677,351 - Li , et al. January 13, 2
2004-01-13
Pyrazinones, compositions containing such compounds and methods of use
App 20030236402 - Han, Yongxin ;   et al.
2003-12-25
Method of treating colonic adenomas
Grant 6,649,649 - Kargman , et al. November 18, 2
2003-11-18
Tri-aryl-substituted-ethane PDE4 inhibitors
Grant 6,639,077 - Cote , et al. October 28, 2
2003-10-28
Method for treating or preventing emesis
Grant 6,610,720 - Robichaud August 26, 2
2003-08-26
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
Grant RE38,103 - Guay , et al. April 29, 2
2003-04-29
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20030065011 - Dube, Daniel ;   et al.
2003-04-03
Gamma-ketoacid dipeptides as inhibitors of caspase-3
Grant 6,525,025 - Han , et al. February 25, 2
2003-02-25
High level expression of human cyclooxygenase-2
App 20030032789 - O'Neill, Gary P. ;   et al.
2003-02-13
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
Grant 6,498,151 - Li , et al. December 24, 2
2002-12-24
Tri-aryl-substituted-ethane PDE4 inhibitors
App 20020173661 - Freisen, Richard ;   et al.
2002-11-21
Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor
Grant 6,448,274 - Friesen , et al. September 10, 2
2002-09-10
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
Grant 6,410,583 - Labelle , et al. June 25, 2
2002-06-25
Methods of identifying modulators of a DP prostaglandin receptor
Grant 6,395,499 - Abramovitz , et al. May 28, 2
2002-05-28
Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)
Grant 6,365,592 - Leblanc , et al. April 2, 2
2002-04-02
Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses
Grant 6,329,137 - Cromlish , et al. December 11, 2
2001-12-11
Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
Grant 6,329,421 - Prasit , et al. December 11, 2
2001-12-11
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
Grant 6,316,472 - Frenette , et al. November 13, 2
2001-11-13
Prostaglandin receptor ligands
App 20010031766 - Belley, Michel ;   et al.
2001-10-18
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
Grant 6,242,493 - Gareau , et al. June 5, 2
2001-06-05
Synthesis of 4-[(5-substituted phenyl)-3-substituted-1H-pyrazol-1-yl]benzenesulfonamide
Grant 6,232,472 - O'Shea , et al. May 15, 2
2001-05-15
Diaryl-2-(5H)-furanones as Cox-2 inhibitors
Grant 6,222,048 - Black , et al. April 24, 2
2001-04-24
PDE IV inhibiting compounds, compositions and methods of treatment
Grant 6,204,275 - Friesen , et al. March 20, 2
2001-03-20
Heterosubstituted pyridine derivatives as PDE4 inhibitors
Grant 6,200,993 - Cote , et al. March 13, 2
2001-03-13
Transgenic mouse having a disrupted amyloid precursor protein gene
Grant 6,187,992 - Zheng , et al. February 13, 2
2001-02-13
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
Grant 6,180,650 - Frenette , et al. January 30, 2
2001-01-30
Synthesis of 4-[5-substituted or unsubstituted phenyl)-3-substituted-1H-pyrazol-1-yl]benzenesulfonamides
Grant 6,150,534 - O'Shea , et al. November 21, 2
2000-11-21
Diaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective cyclooxygenase-2-inhibitors
Grant 6,133,292 - Wang , et al. October 17, 2
2000-10-17
Prostaglandin conjugates for treating or preventing bone disease
Grant 6,121,253 - Han , et al. September 19, 2
2000-09-19
3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
Grant 6,057,319 - Black , et al. May 2, 2
2000-05-02
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
Grant 6,046,217 - Friesen , et al. April 4, 2
2000-04-04
DNA encoding prostaglandin receptor DP
Grant 5,958,723 - Abramovitz , et al. September 28, 1
1999-09-28
Method for measuring metaplastic changes of mucus secreting epithelial cells
Grant 5,932,481 - Pon , et al. August 3, 1
1999-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed